"Saint Joseph Mercy Health System (SJMHS) is a health care organization serving seven counties in southeast Michigan including Livingston, Washtenaw, Wayne, Oakland, Macomb, Jackson, and Lenawee. It includes 548-bed St. Joseph Mercy Ann Arbor, 497-bed St. Joseph Mercy Oakland in Pontiac, 304-bed St. Mary Mercy Livonia, 66-bed St. Joseph Mercy Livingston in Howell, and 133-bed St. Joseph Mercy Chelsea."

During the past decade, Saint Joseph Mercy Hospital conducted 256 clinical trials. In the 10-year time frame, 256 clinical trials started and 217 clinical trials were completed, i.e. on average, 84.8% percent of trials that started reached the finish line to date. In the past 5 years, 108 clinical trials started and 118 clinical trials were completed. i.e. 109.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Mercy Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 194 trials, followed by "SWOG Cancer Research Network" with 48 trials sponsored, "Alliance for Clinical Trials in Oncology" with 45 trials sponsored, "NRG Oncology" with 23 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 23 trials sponsored. Other sponsors include 137 different institutions and companies that sponsored additional 77 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 175 trials as a collaborator, "NRG Oncology" with 53 trials as a collaborator, "Canadian Cancer Trials Group" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 7 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 88 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Mercy Hospital" are "Stage IV Lung Cancer AJCC v8" (16 trials), "Recurrent Ovarian Carcinoma" (14 trials), "Recurrent Breast Carcinoma" (13 trials), "Colorectal Cancer" (11 trials) and "Fallopian Tube Transitional Cell Carcinoma" (11 trials). Many other conditions were trialed in "Saint Joseph Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Saint Joseph Mercy Hospital" are "Drug" (353 trials), "Other" (246 trials), "Biological" (143 trials), "Procedure" (92 trials) and "Radiation" (77 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (121 trials), "Quality-of-Life Assessment" (102 trials), "Questionnaire Administration" (62 trials), "Paclitaxel" (56 trials) and "Carboplatin" (51 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Mercy Hospital" are 370 trials for "All" genders, 82 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Mercy Hospital". undefined are not yet recruiting, 99 are recruiting, 165 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 146 completed trials in Saint Joseph Mercy Hospital, 9 suspended trials, and 42 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Mercy Hospital, 19 "Phase 1" clinical trials were conducted, 222 "Phase 2" clinical trials and 207 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 42 trials that are defined as “Not Applicable".

Saint Joseph Mercy Hospital has several departments that took part in Clinical trials: "Saint Joseph Mercy Cancer Center" - 181 trials, "Lakeland Regional Cancer Care Center - St. Joseph" - 43 trials, "Michigan Heart, PC" - 17 trials, "St. Joseph Mercy Hospital- Inpatient Pharmacy" - 2 trials